ReviewZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026
[Imaging assessment and treatment of Charcot arthropathy of the shoulder assisted by NGH classification].
Review in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Charcot arthropathy of the shoulder is a rare destructive joint disorder that is most commonly secondary to syringomyelia and often leads to osteolysis of the shoulder joint and severe upper limb dysfunction. The diagnostic and therapeutic challenges of this condition lie not merely in identifying joint destruction, but in the nonspecific nature of its early clinical manifestations, which may mimic infection, tumor, or inflammatory arthropathy. In addition, the extent of bone destruction in the glenoid and humeral head may vary considerably, making conventional imaging descriptions insufficient for preoperative assessment and treatment decision-making. The neuropathic gleno-humeral degeneration (NGH) classification independently evaluates the degenerative changes of the glenoid and humeral head on imaging. This classification helps reduce ambiguity in radiographic descriptions and provides a reference for clinical surgical decision-making. Current evidence suggests that the management of Charcot arthropathy of the shoulder should be based on comprehensive assessment: Radiography may be used for initial diagnosis with assistance from the NGH classification; magnetic resonance imaging can evaluate soft tissue conditions and related abnormalities; and computed tomography with three-dimensional reconstruction is useful for quantifying bone defects and planning prosthetic implantation. In patients with swelling, joint effusion, elevated inflammatory markers, or planned surgery, joint aspiration and biopsy should be considered to exclude infection, tumor, and inflammatory joint diseases. For patients whose joint destruction has entered a quiescent phase, shoulder arthroplasty and other surgical procedures may be considered. In the future, multi-center and prospective cohort studies, and long-term follow-up are still needed to further validate the clinical value of NGH classification and clarify the long-term efficacy of shoulder replacement surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.